Clinical trial
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients…
NCT00354744 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00354744 |
|---|---|
| Title | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma |
| Official title | Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | dactinomycin, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, irinotecan hydrochloride, vincristine sulfate, conventional surgery, radiation therapy, filgrastim |
| Enrollment | 109 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jun 30, 2019 |
| First posted | Jul 20, 2006 |
| Last update posted | Jan 29, 2020 |
| Countries | Australia, Canada, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: